ENDPOINTS

Another Chinese biotech files to go public in Hong Kong; A new ROR1 ADC deal

Plus, news about Harmony Biosciences and Reverb Therapeutics: Genuine Biotech files for HKEX listing: The drug developer, which has multiple locations in China, joins a growing list of biotechs seeking to ...

Feb 19, 2025 - 16:09
 0
Another Chinese biotech files to go public in Hong Kong; A new ROR1 ADC deal
Plus, news about Harmony Biosciences and Reverb Therapeutics: Genuine Biotech files for HKEX listing: The drug developer, which has multiple locations in China, joins a growing list of biotechs seeking to ...
Read More

Tags:

Previous Article

Patient-Centered Mobile Imaging – Akumin Shows How It’s Done

Next Article

What’s next for the World Health Organization? US exit could reshape agency

Related Posts

Odyssey reportedly underwent layoffs; GSK to move vaccine R&D site to Cambridge

Odyssey reportedly underwent layoffs; GSK to move vacci...

Feb 12, 2025  0

Moderna earnings: Losses narrow as biotech cuts costs

Moderna earnings: Losses narrow as biotech cuts costs

Feb 14, 2025  0

Novartis returns for its anticoagulant in up to $3.1B buy of Blackstone’s Anthos

Novartis returns for its anticoagulant in up to $3.1B b...

Feb 11, 2025  0